Skip to main content

1 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Investors support new antifungal agent

Sunday 13 September 2020

Interviewee/Contributor

Ralf Schmid and Emma Harvey

Organisation

F2G Ltd

Organisations

KEMRI Wellcome Trust Research Programme
Humabs BioMed SA
Results Healthcare
Marks & Clerk LLP
Truffle Capital
IBA Molecular
Ilyine Ltd
Provecs Medical GmbH
Allero Therapeutics BV
European Medicines Agency

Interviewees and Contributers

Arnaud Foussat
Paul Higham
Kevin Johnson
Christian Rohlff
Jean-Claude Muller
Rudy Dekeyser
Martin Fussenegger
Michael Dabrowski
Tim Farries
Nicholas Adams

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form